greeksoup/ stock research

Lemaitre Vascular (LMAT) FY2024 results: revenue $220 million, up 13.6% on the year

Lemaitre Vascular Inc. (LMAT) reported revenue of $220 million for fiscal 2024, the year ended 31 December 2024, up 13.6% on the year before. Net income was $44 million, up 46.3%, and diluted earnings per share $1.93. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2025.

Revenue
$220 million
+13.6% on the year
FY2017FY2024
Operating margin
23.8%
19.0% a year earlier
FY2017FY2024
Net income
$44 million
+46.3% on the year
FY2017FY2024
Diluted EPS
$1.93
+44.0% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue220193162+13.6%
Cost of revenue69.066.456.8+3.8%
Gross profit151127105+18.8%
Gross margin68.6%65.7%64.9%
Research and development15.717.013.3-7.8%
Operating income52.336.726.8+42.3%
Operating margin23.8%19.0%16.6%
Interest expense0.20.00.0
Pre-tax income56.939.527.5+44.1%
Income tax12.89.46.9+37.0%
Effective tax rate22.6%23.7%24.9%
Net income44.030.120.6+46.3%
Net margin20.0%15.6%12.8%
Diluted EPS$1.93$1.34$0.93+44.0%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow44.136.825.4+20.1%
Capital expenditure7.07.33.2-4.2%
Free cash flow37.229.522.1+26.0%
Free cash flow margin16.9%15.2%13.7%
Cash from investing-200-24.7-10.4
Cash from financing158-7.1-9.2
Depreciation and amortisation9.69.59.4+1.0%
Share-based compensation6.65.34.2+23.5%
Buybacks1.70.90.6+101.5%
Dividends paid14.412.411.0+15.5%
Dividend per share$0.64$0.56$0.50+14.3%
Diluted shares, weighted23m22m22m+1.6%
Shares outstanding at period end23mn/an/a

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity337298268+13.2%
Debt1680.00.0
Operating lease liabilities15.216.614.7-8.4%
Other liabilities31.532.327.6-2.3%
Total liabilities and equity552347310+59.1%
Fixed assets24.821.817.9+14.0%
Goodwill65.965.965.90.0%
Intangible assets35.841.746.5-14.1%
Investments27480.863.6+239.2%
Cash and equivalents25.624.319.1+5.5%
Receivables30.125.122.0+19.9%
Other assets95.587.275.4+9.4%
Total assets552347310+59.1%

10-K for the year ended 31 December 2024, filed 28 February 2025: the filing.